Doxorubicin-induced glomerulosclerosis with proteinuria in GFP-GABARAP transgenic mice

Miyuki Takagi-Akiba1, Katsuhiko Asanuma, Isei Tanida

  • 1Div. of Nephrology, Dept. of Internal Medicine, Juntendo Univ., Hongo, Bunkyo-ku, Tokyo, Japan.

Insights

Green fluorescent protein-gamma-aminobutyric acid A receptor-associated protein (GFP-GABARAP) transgenic mice showed worsened kidney damage after doxorubicin treatment. The GFP-GABARAP/p62 complex impairs glomerular function and delays recovery.

Area of Science:

  • Cell Biology
  • Nephrology
  • Molecular Biology

Background:

  • Autophagy, a cellular degradation process, is crucial for maintaining cellular homeostasis, but its role in kidney glomerular function remains unclear.
  • Dysfunctional autophagy is linked to various pathological conditions.
  • LC3, an autophagy executor, has shown importance in podocyte damage recovery.

Purpose of the Study:

  • To investigate the role of gamma-aminobutyric acid A receptor-associated protein (GABARAP), an LC3 homolog, in kidney glomerular function.
  • To determine the impact of GABARAP overexpression in podocytes on kidney response to doxorubicin-induced injury.

Main Methods:

  • Generation of green fluorescent protein (GFP)-GABARAP transgenic mice with abundant GFP-GABARAP expression in glomerular podocytes.
  • In vitro assessment of autophagic activity in isolated podocytes.
  • Administration of a single doxorubicin injection to transgenic and wild-type mice to evaluate kidney damage, proteinuria, and glomerular sclerosis.
  • Immunofluorescence and biochemical analyses to assess GABARAP localization and colocalization with p62.

Main Results:

  • Transgenic mice exhibited no apparent phenotype or altered in vitro autophagic activity compared to wild-type mice.
  • Doxorubicin treatment led to significantly increased proteinuria and glomerular sclerosis in transgenic mice versus wild-type controls.
  • Neither GFP-GABARAP nor endogenous GABARAP were recruited to autophagosomes post-doxorubicin; they remained in the cytosol.
  • Cytosolic GFP-GABARAP colocalized with p62, forming aggregates.

Conclusions:

  • Overexpression of GFP-GABARAP in podocytes does not affect basal autophagic activity but exacerbates doxorubicin-induced kidney injury.
  • The formation of a GFP-GABARAP/p62 complex in the cytosol, rather than recruitment to autophagosomes, is associated with impaired glomerular function.
  • This complex appears to hinder recovery from doxorubicin-induced podocyte damage, highlighting a novel mechanism of kidney dysfunction.

Related Concept Videos